After ten years of generics, Anvisa advocates increased sales in the country
This article was translated by an automatic translation system, and was therefore not reviewed by people.
After ten years of generics, Anvisa advocates increased sales in the country
Paula Laboissière
Reporter Agency Brazil
Production of generic drugs grew 100% in aa country since market entry in 1999
Brasília - While considering the 18% share of the generic pharmaceutical market in a good performance in the last ten years, the director-president of the National Health Surveillance Agency (Anvisa), Dirceu Raposo, admits that there is ignorance and resistance by the people's time to abandon the so-called reference medicinal product for cheaper.
In an interview to Agência Brasil, he estimated that the prevalence of generic brands on the issue in Brazil is a "purely educational." Dirceu demanded greater effort by the doctors as they prescribe the drugs and the pharmacists so that, during the service, make reference to the availability of cheaper drugs.
"It is important that the doctor, to prescribe, makes clear that any of these two types of medicine can meet the need of treatment. For the patient knows who is available to drugs with the same quality, efficacy and safety of the brand that, in most cases it costs more expensive. "
The chairman of the Anvisa argued that we need more disclosure of generics by the manufacturers themselves, but given the representation of 18% of medicine in the pharmaceutical market for the period of deployment, considered short.
Dirceu noted that in European countries and North America, the generics are sold for about 30 years. In the United States, for example, the sale of cheaper drugs accounts for 50% of the pharmaceutical market.
"Why be a copy of a product that already exists on the market, the general has some advantages of the economic point of view also the manufacturer. No need to invest in research, reach the middle class showing its therapeutic capabilities. "
Commenting on the strength of Brazilian doctors to prescribe the right medicine cheaper, he said the situation was worse when the 9787 Act - which provides for generic - was created on February 10, 1999. Dirceu ensures that the product is equivalent from a therapeutic and that the process of treatment as the end result is the same in both cases.
However, Anvisa warns the doctor, when prescribing medicines, may prohibit sustituição of the generic brand of medicine. But the ban is valid only if the written notice on a prescription.
"It is envisaged in the law that the pharmacist can do to replace the generic medicine prescribed by the correspondent. It is important that people learn and become accustomed to seek the pharmacist. Every pharmacy in Brazil must have available to pharmacists. If not, the patient has to turn its back and try another, "he added.
Dirceu noted that manufacturers of generic survive the expiration of patents on medicines for reference and for the years ahead, the forecast is that new products enter the Brazilian pharmaceutical market. Highlights among them are the generic version of Viagra and medicines to the central nervous system.
Source: Agência Brasil
Our stories are taken in full of the sites of our partners. Therefore, we can not change the contents of these cases even of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Important:
The JurisWay site does not interfere in the work provided by doctrine, why only reflect the opinions, ideas and concepts of their authors.
